Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Power Life Sciences

Status: Not yet enrolling

Conditions: Recurrent Ovarian Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT06070285

72827906

Details and patient eligibility

About

Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption.

By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.

Enrollment: 500 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged ≥ 18 years old
• Able to comprehend the investigational nature of the protocol and provide informed consent
• Diagnosis of recurrent ovarian cancer

Exclusion criteria

• No diagnosis of recurrent ovarian cancer confirmed
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Trial design